N-of-1 trials: not just for academics.
作者信息
Federman Daniel G, Shelling Michael L, Kirsner Robert S
出版信息
J Gen Intern Med. 2011 Feb;26(2):115. doi: 10.1007/s11606-010-1554-z.
Abstract
摘要
相似文献
1
N-of-1 trials: not just for academics.单病例试验：不仅适用于学术界。
J Gen Intern Med. 2011 Feb;26(2):115. doi: 10.1007/s11606-010-1554-z.
2
Using N-of-1 trials to improve patient management and save costs.使用 N-of-1 试验改善患者管理并节省成本。
J Gen Intern Med. 2010 Sep;25(9):906-13. doi: 10.1007/s11606-010-1352-7. Epub 2010 Apr 13.
3
Comparative effectiveness, personalized medicine and innovation: the path forward.比较效果、个性化医疗与创新：前进之路。
Pharmacoeconomics. 2010;28(10):923-30. doi: 10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000.
4
Conducting economic evaluation based on basket clinical trial in the area of precision medicine.基于精准医学领域的篮子临床试验进行经济评估。
Expert Rev Pharmacoecon Outcomes Res. 2021 Apr;21(2):169-171. doi: 10.1080/14737167.2021.1865158. Epub 2020 Dec 24.
5
Coverage With Evidence Development and Managed Entry in the Funding of Personalized Medicine: Practical and Ethical Challenges for Oncology.有证据开发的覆盖范围和管理进入个性化药物的资金：肿瘤学的实际和伦理挑战。
J Clin Oncol. 2015 Dec 1;33(34):4112-7. doi: 10.1200/JCO.2015.61.2838. Epub 2015 Oct 12.
6
Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials.促进药物使用监测和简短信息传递的干预措施对2型糖尿病患者药物依从性的影响：随机试验的系统评价
Diabet Med. 2016 May;33(5):565-79. doi: 10.1111/dme.12987. Epub 2015 Nov 17.
7
Realizing the Full Potential of Precision Medicine in Health and Health Care.实现精准医学在健康与医疗保健中的全部潜力。
JAMA. 2016 Oct 25;316(16):1659-1660. doi: 10.1001/jama.2016.14117.
8
Proof or consequences: who shall pay for the evidence in pain medicine?证据还是后果：疼痛医学中的证据应由谁来买单？
Pain Med. 2010 Jan;11(1):1-2. doi: 10.1111/j.1526-4637.2009.00770.x.
9
Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?推动药物基因组学成为精准医学的一部分：方式、地点和对象？
Clin Pharmacol Ther. 2016 Feb;99(2):154-6. doi: 10.1002/cpt.273. Epub 2015 Nov 9.
10
Next generation evidence-based medicine: individualised, personalised and humanised.下一代循证医学：个体化、个性化与人性化。
Int J Rheum Dis. 2013 Dec;16(6):615. doi: 10.1111/1756-185X.12286.
引用本文的文献
1
Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research.单病例（n-of-1）试验：一种以患者为中心的比较有效性研究的实用临床决策方法。
J Clin Epidemiol. 2013 Aug;66(8 Suppl):S21-8. doi: 10.1016/j.jclinepi.2013.04.006.
2
Determining whether a patient is feeling better: pitfalls from the science of human perception.判断患者是否感觉好转：人类感知科学中的陷阱。
J Gen Intern Med. 2011 Aug;26(8):900-6. doi: 10.1007/s11606-011-1655-3. Epub 2011 Feb 19.
本文引用的文献
1
N-of-1 trials: a new future?单病例试验：新的未来？
J Gen Intern Med. 2010 Sep;25(9):891-2. doi: 10.1007/s11606-010-1440-8.
2
Using N-of-1 trials to improve patient management and save costs.使用 N-of-1 试验改善患者管理并节省成本。
J Gen Intern Med. 2010 Sep;25(9):906-13. doi: 10.1007/s11606-010-1352-7. Epub 2010 Apr 13.
Zotero 插件